pharmacie et médicaments – Autorisation de mise sur le marche du Palovarotène

This written question concerns the marketing authorization process for the drug Palovarotene. It seeks clarification on the procedures and criteria used by regulatory bodies in evaluating and approving new medications. The question is posed by a Member of Parliament and is relevant to patients, healthcare providers, and the pharmaceutical industry, impacting access to new treatments.